Basic information Safety Supplier Related
ChemicalBook >  Product Catalog >  Pharmaceutical intermediates >  Heterocyclic compound >  2-chloro-8-cyclopentyl-5-Methylpyrido[2,3-d]pyriMidin-7(8H)-one

2-chloro-8-cyclopentyl-5-Methylpyrido[2,3-d]pyriMidin-7(8H)-one

Basic information Safety Supplier Related

2-chloro-8-cyclopentyl-5-Methylpyrido[2,3-d]pyriMidin-7(8H)-one Basic information

Product Name:
2-chloro-8-cyclopentyl-5-Methylpyrido[2,3-d]pyriMidin-7(8H)-one
Synonyms:
  • 2-chloro-8-cyclopentyl-5-Methylpyrido[2,3-d]pyriMidin-7(8H)-one
  • Pyrido[2,3-d]pyriMidin-7(8H)-one, 2-chloro-8-cyclopentyl-5-Methyl-
  • 2-chloro-8-cyclopentyl-5-Me
  • Palbociclib Intermediate2
  • Palbociclib intermediates
  • 2-Chloro-8-cyclopentyl-5-methyl-8H-pyrido[2,3-d]pyrimidin-7-one (For Palbociclib)
  • 2-chloro-8-cyclopentyl-5-methylpyrido[2,3-d]pyrimidin-7-one
  • 2-chloro-8-cyclopentyl-5-methyl-7H,8H-pyrido[2,3-d]pyrimidin-7-one
CAS:
1013916-37-4
MF:
C13H14ClN3O
MW:
263.72
EINECS:
800-066-8
Product Categories:
  • Anticancer
  • 1013916-37-4
Mol File:
1013916-37-4.mol
More
Less

2-chloro-8-cyclopentyl-5-Methylpyrido[2,3-d]pyriMidin-7(8H)-one Chemical Properties

Melting point:
176 - 178°C
Boiling point:
428.0±34.0 °C(Predicted)
Density 
1.346±0.06 g/cm3(Predicted)
storage temp. 
under inert gas (nitrogen or Argon) at 2-8°C
solubility 
Chloroform (Slightly), Methanol (Slightly)
form 
Solid
pka
0.82±0.20(Predicted)
color 
Yellow to Dark Yellow
Water Solubility 
Slightly soluble in water.
InChI
InChI=1S/C13H14ClN3O/c1-8-6-11(18)17(9-4-2-3-5-9)12-10(8)7-15-13(14)16-12/h6-7,9H,2-5H2,1H3
InChIKey
BSKNQSYIDZUXQT-UHFFFAOYSA-N
SMILES
C1(Cl)=NC=C2C(C)=CC(=O)N(C3CCCC3)C2=N1
More
Less

2-chloro-8-cyclopentyl-5-Methylpyrido[2,3-d]pyriMidin-7(8H)-one Usage And Synthesis

Description

2-chloro-8-cyclopentyl-5-Methylpyrido[2,3-d]pyriMidin-7(8H)-one is used as an intermediate for Palbociclib, a CDK 4/6 inhibitor used to treat patients with hormone receptor (HR)-positive, HER-2-negative advanced or metastatic (cancer that has spread) breast cancer.

Uses

2-Chloro-8-cyclopentyl-5-methyl-8H-pyrido[2,3-d]pyrimidin-7-one is used as pharmaceutical intermediate.

Synthesis

733039-20-8

107-93-7

1013916-37-4

To the reaction vessel was added 5-bromo-2-chloro-N-cyclopentyl-4-pyrimidinamine (10.0 g, 1.0 eq.) and N-methylpyrrolidone (NMP, 50 mL, 5.0 vol.) at room temperature. Subsequently, crotonic acid (4.7 g, 1.5 eq.) and triethylamine (20.2 mL, 4.0 eq.) were added to the reaction mixture. The vessel was degassed and purged three times with nitrogen. Palladium acetate (Pd(OAc)2, 0.25 g, 0.03 eq.) was added to the degassed reaction mixture. The vessel was again degassed and purged with nitrogen three times in the same manner. The reaction mixture was heated to 65 °C and stirred continuously until the feedstock was completely consumed (at least 6 hours). Then, acetic anhydride (6.8 mL, 2.0 eq.) was added to the reaction mixture. The reaction was kept at 65 °C until the feedstock was completely consumed (usually takes 1-2 hours). Upon completion of the reaction, the mixture was cooled to 20 °C and water (100 mL, 10 v/v) was added to dissolve the triethylamine-HBr salt while 2-chloro-8-cyclopentyl-5-methyl-8H-pyrido[2,3-d]pyrimidin-7(8H)-one was precipitated. The precipitate was stirred at 20°C for 1 hour. The solid was collected by filtration and washed sequentially with a mixture of water (20 mL, 2.0 v/v) and isopropanol/water (4:1, 50 mL, 5.0 v/v). Finally, the crude product was vacuum dried at 55-70 °C to afford 2-chloro-8-cyclopentyl-5-methyl-8H-pyrido[2,3-d]pyrimidin-7(8H)-one (7.8 g, 81% yield) as a tan to gray solid.

References

[1] Patent: WO2014/128588, 2014, A1. Location in patent: Page/Page column 34; 35
[2] Patent: WO2008/32157, 2008, A2. Location in patent: Page/Page column 26

2-chloro-8-cyclopentyl-5-Methylpyrido[2,3-d]pyriMidin-7(8H)-oneSupplier

Tianjin Branch Chong pharmaceutical intermediates Co., Ltd. Gold
Tel
022-60116533 13207668525
Email
saleskc@scipharmacn.com
Shanghai Haoyuan Chemexpress Co., Ltd. Gold
Tel
021-58950125
Email
info@chemexpress.com
Jinan Duowei Innovation Biotechnology Co., Ltd Gold
Tel
0531-58595315 13864187945
Email
415834789@qq.com
Shanghai Haohong Pharmaceutical Co., Ltd. Gold
Tel
400-8210725 400821072
Email
malulu@leyan.com
TIANJIN PHARMACN MEDICAL TECHNOLOGY CO.,LTD.
Tel
022-60189726 18812034280
Email
188120342808@163.com